Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma. - Okamoto H; Yoshimatsu Y; Tomizawa T; Kunita A; Takayama R; Morikawa T; Komura D; Takahashi K; Oshima T; Sato M; Komai M; Podyma-Inoue KA; et al. (Scientific reports, 2019)